These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8639840)

  • 21. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function.
    Nyberg P; Dahlbäck B; García de Frutos P
    FEBS Lett; 1998 Aug; 433(1-2):28-32. PubMed ID: 9738926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S.
    Tran S; Dahlbäck B
    J Thromb Haemost; 2010 Jan; 8(1):129-36. PubMed ID: 19874463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.
    van de Poel RH; Meijers JC; Bouma BN
    Thromb Haemost; 2001 May; 85(5):761-5. PubMed ID: 11372664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
    Aparicio C; Dahlbäck B
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF; Kalafatis M; Shatos M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of factor Va and factor VIIIa by activated platelets.
    Kalafatis M; Rand MD; Jenny RJ; Ehrlich YH; Mann KG
    Blood; 1993 Feb; 81(3):704-19. PubMed ID: 8427963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
    Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the molecular defect in factor VR506Q.
    Kalafatis M; Bertina RM; Rand MD; Mann KG
    J Biol Chem; 1995 Feb; 270(8):4053-7. PubMed ID: 7876154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the membrane in the inactivation of factor Va by activated protein C.
    Kalafatis M; Mann KG
    J Biol Chem; 1993 Dec; 268(36):27246-57. PubMed ID: 8262965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of P4-P3' residues flanking Arg336 in facilitating activated protein C-catalyzed cleavage and inactivation of factor VIIIa.
    DeAngelis JP; Varfaj F; Wakabayashi H; Fay PJ
    Thromb Res; 2011 Nov; 128(5):470-6. PubMed ID: 21470668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor V and thrombotic disease: description of a janus-faced protein.
    Nicolaes GA; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa.
    Shen L; Dahlbäck B
    J Biol Chem; 1994 Jul; 269(29):18735-8. PubMed ID: 8034625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors.
    Giri TK; Yamazaki T; Sala N; Dahlbäck B; de Frutos PG
    Blood; 2000 Jul; 96(2):523-31. PubMed ID: 10887114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation.
    Maurissen LF; Thomassen MC; Nicolaes GA; Dahlbäck B; Tans G; Rosing J; Hackeng TM
    Blood; 2008 Mar; 111(6):3034-41. PubMed ID: 18160668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va.
    Tran S; Norstrøm E; Dahlbäck B
    J Biol Chem; 2008 Mar; 283(11):6648-55. PubMed ID: 18198180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretable human platelet-derived factor V originates from the plasma pool.
    Camire RM; Pollak ES; Kaushansky K; Tracy PB
    Blood; 1998 Nov; 92(9):3035-41. PubMed ID: 9787136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase.
    O'Brien LM; Mastri M; Fay PJ
    Blood; 2000 Mar; 95(5):1714-20. PubMed ID: 10688829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.